-
on drug development, uncovering basic mechanisms, and identifying novel therapeutic targets in leukemogenesis and solid tumors. Specifically, we study genetic and epigenetic biomarkers with prognostic value
-
are looking for a highly motivated candidate with a PhD and/or MD degree interested in combining novel rational and combinatorial synthetic biology approaches with computational methods to develop strategies
-
data and health record information, to develop predictive models for drug response. Furthermore, we work on creating new treatment stratification methods to personalize treatment for individual patients
-
bone marrow transplantation. We are looking for a highly motivated candidate with a PhD degree interested in using microbiological methods with the aim of developing novel strategies to improve bone
-
drug development, with strong potential for publication in high-impact journals. Our research aims to uncover fundamental mechanisms of leukemogenesis and solid tumor progression, with a particular
-
pioneering the development of neural stem cell (NSC) and extracellular vesicle (EV)-based therapies for neurodegenerative conditions, including traumatic brain injury (TBI), chemotherapy-related cognitive
-
Epigenetics, Epigenetics Regulation, Cancer Metabolism, Immunology, Drug Discovery, Development, and Structural Biology, with an emphasis on RNA epigenetics/epitranscriptomics (RNA modifications) and RNA-based
-
discovery approaches and biochemical assays to target key proteins. This funded position is for a postdoctoral trainee interested in aiding the development of novel therapeutics for treating cancer
-
of Hope. This role offers an exciting opportunity to investigate immune checkpoint signaling within the tumor microenvironment and contribute to the development of novel anticancer therapies
-
therapeutics or nucleic-acid chemistry o Nanoparticle / liposome formulation and characterization o HTS assay development and robotic screening o Recombinant protein expression in multiple hosts o